SearchipHandbook Blog
Your source for expert commentary on IP management issues.
In ipHandbook Forums
|
Home > Author Index > WYSE, Roger E WYSE, Roger E
Dr. Wyse chairs or serves on the boards of 11 private companies. He is Co-Chairman of the newly formed $150 million Malaysian Life Capital Fund. He is also a member of the International Advisory Panel for Biotechnology (BioIAP) for the Prime Minister of Malaysia. He was founder and Chairman of the Alliance for Animal Genome Research. He has over 27 years of experience as an internationally recognized scientist and as a dean at two major research universities, Rutgers and the University of Wisconsin-Madison. Before joining Burrill & Company, Dr. Wyse served for five years as Dean of the College of Agricultural and Life Sciences at the University of Wisconsin-Madison. From 1986 to 1992, he was Dean of Research at Rutgers University. Dr. Wyse earned international recognition for his basic studies in plant biochemistry. He has published over 150 scientific papers. In 1982, he received the prestigious Arthur Flemming Award for the Outstanding Young Scientist in the U.S. Federal Service. He was elected a Fellow of both the Crop Science Society of America and The American Society of Agronomy. He has also served as a consultant to numerous Fortune 500 companies.
Contributions
|
|
About the ipHandbook | Policies and Disclaimers | Contact Us | Site Map
Developed with support from the Rockefeller Foundation. Distributed through Sponsorship.
©2007-2009. Concept Foundation, PIPRA, FIOCRUZ and bioDevelopments-Int.
Institute. Copyright and use. 
Printer Friendly
Roger E. Wyse is Managing Director and General Partner of Burrill & Company, a life sciences merchant bank and leading life sciences venture capital firm located in San Francisco, California. Dr. Wyse joined Burrill & Company in 1998 and has overseen venture capital investing, partnering, and the spinout of technology from large companies in the agricultural, nutraceutical, health and wellness, and industrial biotechnology fields. The firm has over $850 million under management.
Show All Abstracts
Abstract